Literature DB >> 14684611

Regulation of cyclooxygenase expression by vasopressin in rat renal medulla.

Ming-Zhi Zhang1, Pedro Sanchez Lopez, James A McKanna, Raymond C Harris.   

Abstract

The antagonism between prostaglandin and vasopressin represents a classic negative feedback loop. It is not clear whether cyclooxygenase (COX)-2 and/or COX-1 expression is involved in elevated prostaglandin production stimulated by vasopressin in vivo. In the present study, we explored vasopressin regulation of medullary COX-2 and COX-1 expression acutely and chronically in rats. Medullary COX-1 expression was moderately lower and COX-2 expression was significantly lower in adult male Brattleboro rats than age-matched Long-Evans controls. Chronic treatment of Brattleboro rats with vasopressin for 1 wk led to a decrease in urine volume and a moderate increase in medullary COX-1; in contrast, medullary COX-2 expression was almost undetectable in untreated rats but was dramatically up-regulated with vasopressin treatment and was accompanied by increased urinary prostaglandin E(2) excretion. Further investigation revealed that both V1 and V2 receptors were involved in chronic medullary COX-1 and COX-2 up-regulation. Acute treatment with specific V1 or V2 receptor agonists resulted in specific increases in medullary COX-2, which was prevented by furosemide. Vasopressin did not affect COX-2 expression in cultured renomedullary interstitial cells. These data demonstrate that vasopressin stimulates medullary COX-2 expression through activation of both V1 and V2 receptors, and this stimulation is indirect and probably involves increased medullary electrolyte tonicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684611     DOI: 10.1210/en.2003-0903

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Assessing the application of tissue microarray technology to kidney research.

Authors:  Ming-Zhi Zhang; Yinghao Su; Bing Yao; Wei Zheng; Mark Decaestecker; Raymond C Harris
Journal:  J Histochem Cytochem       Date:  2010-01-19       Impact factor: 2.479

Review 2.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

3.  Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/- mouse model of autosomal dominant polycystic kidney disease.

Authors:  Md Monirujjaman; Harold M Aukema
Journal:  J Nephrol       Date:  2019-01-22       Impact factor: 3.902

4.  Prorenin Receptor, a Necessary Component in Urine Concentration Mechanism.

Authors:  Boye L Jensen
Journal:  J Am Soc Nephrol       Date:  2016-04-20       Impact factor: 10.121

5.  Notch signaling is essential in collecting duct epithelial cell fate determination during development and maintenance of cell type homeostasis in adult.

Authors:  Ming-Zhi Zhang
Journal:  Ann Transl Med       Date:  2019-12

6.  Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.

Authors:  Yu Pan; Shirong Cao; Andrew S Terker; Jiaqi Tang; Kensuke Sasaki; Yinqiu Wang; Aolei Niu; Wentian Luo; Xiaofeng Fan; Suwan Wang; Matthew H Wilson; Ming-Zhi Zhang; Raymond C Harris
Journal:  Kidney Int       Date:  2021-11-11       Impact factor: 10.612

7.  ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.

Authors:  Fenghua Zeng; Ming-Zhi Zhang; Amar B Singh; Roy Zent; Raymond C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

8.  Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney.

Authors:  Raymond C Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.